Result

Amerise Biosciences' board has approved the financial results for the quarter ended June 30, 2025. For the quarter, the company reported revenue from operations of 0.0637 Cr, a notable decrease from 0.1880 Cr in the prior year's comparable quarter.

The company also registered a net loss of 0.0081 Cr, a shift from a profit of 0.1059 Cr in the same period last year.

This indicates a challenging operational quarter for the company, impacting its profitability and reflecting a decline in business performance compared to the previous year.